Schedule 13G ownership disclosure

OS THERAPIES INCORPORATED

Common Stock, par value $0.001 per share · CUSIP: 68764Y207

Event date: 2024-12-31

Filing-level shares
1,267,465.00
Percent of class
5.9%
  • Thomas A. Satterfield, Jr.

    Shares: 1,267,465.00 · Class: 5.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-011849
Form type
SCHEDULE 13G/A
Filer
OS Therapies Inc
CIK
CIK 1795091
Filed
Feb 12, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub